Furthermore, it was confirmed that ergotamine can regulate intracellular Ca2+ concentration by inhibiting NR1a/NR2A subunits in vitro, and this result suggests that ergotamine may regulate redox status and may be a potential treatment for several neurological diseases. This evidence concerns the gene GRIN2A and nervous system disorder.